The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Beijing Wehand-Bio Pharmaceutical Co., Ltd.* 北 京 五 和 博 澳 藥 業 股 份 有 限 公 司 (A joint stock company incorporated in the People's Republic of China wit ...

(A joint stock company incorporated in the People's Republic of China with limited liability) WARNING The publication of this announcement is required by The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the Securities and Futures Commission (the "Commission") solely for the purpose of providing information to the public in Hong Kong. The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no repres ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Huge Dental Limited (the "Company") (Incorporated under the laws of the Cayman Islands with limited liability) WARN ...

Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Beijing Wehand-Bio Pharmaceutical Co., Ltd.* 北 京 五 和 博 澳 藥 業 股 份 有 限 公 司 ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. WOLONG ELECTRIC GROUP CO., LTD. 臥龍電氣驅動集團股份有限公司 (a joint stock company incorporated in the People's Republic of China with limited liability) WARNI ...

Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. No offer or invitation will be made to the public in Hong Kong until after a prospectus of the Company h ...

业绩总结 - 2002 - 2024年公司收入复合年增长率为21.9%，净利润复合年增长率为16.2%[47] - 截至2025年9月30日，海外业务收入占全球收入超40%[47] - 2025年前九个月，各业务板块有不同收入、毛利和毛利率[55] - 2023年公司年度利润降幅34.1%，2024年增幅50.5%，2025年前九个月增幅22.3%[78] - 2025年9月30日净流动资产增加，净资产略降[81][82] - 2024 - 2025年前九个月，经营、投资、融资活动净现金有变化[85] - 2025年9月30日公司毛利率为24.5%，净利率为6.9%[86] - 2025年9月30日公司流动比率为1.25，资产负债率为0.58[86] 用户数据 - 公司通过研产销和品牌一体化服务超100个国家和地区的客户[46] - 2022 - 2024年及2025年前九个月，前五大客户销售额占比有变化[67] - 2022 - 2024年及2025年前九个月，最大客户销售额占比有变化[67] 未来展望 - 公司计划成为全球电动驱动解决方案排名第一的企业[62] - 公司预计获得款项用于研发等多方面[89] - 预计开支约为[REDACTED]港元，占[REDACTED]的[REDACTED]%[107] 新产品和新技术研发 - 2022 - 2024年及2025年前九个月研发支出分别为8.186亿等金额[63] 市场扩张和并购 - 截至2025年9月30日，全球有45家工厂，海外14家，已建立21个制造基地[64][95] - 公司持有浙江杭绍合资企业30%股权[174] 其他新策略 - 公司战略扩展至电动航空和具身智能行业[164]

业绩总结 - 2023 - 2025财年收入从3490.4万新元增至4641.7万新元，复合年增长率约15.3%[57] - 2023 - 2025财年毛利从1053万新元增至1924.6万新元，毛利率从30.2%升至41.5%[59] - 2023 - 2025财年税前利润从487.3万新元增至1162.3万新元，净利润从377.9万新元增至971.4万新元，净利润率从10.8%升至21.0%[62] - 2023 - 2025财年毛利率、净利率、净资产收益率、总资产收益率上升，流动比率、速动比率上升，资产负债率下降[64] - 2023 - 2025财年经营活动净现金增加，投资活动和融资活动净现金有波动[69] - 2023 - 2025财年现金及现金等价物从440万新元增加到630万新元[72] - 2023 - 2025财年调整后净利润分别为378万、606.6万、1051.7万新元，调整后净利润率分别为10.8%、14.8%、22.7%[77] - 2023 - 2025财年造船服务收入占比升至30.8%，租船等服务收入占比降至21.1%，航运代理服务收入占比降至42.2%，物料供应等收入占比降至5.9%[43] 用户数据 - 2023 - 2025财年最大客户收入占比分别约为25.6%、20.0%和11.0%，前五大客户收入合计占比分别约为40.2%、33.3%和29.8%[48] 未来展望 - 业务战略包括加强核心能力、扩大船队和物流能力、进行战略投资[85] - 假设以中间价发行获约[具体金额]港元，用于收购开发土地、战略投资/收购等[86][89] 新产品和新技术研发 - 开展B100生物柴油动力工作船1000小时海上试验[181] 市场扩张和并购 - 计划通过扩大造船能力、扩大工作船租赁业务、战略投资/收购等实现扩张[85] 其他新策略 - 采用年度股息政策，宣布和支付的年度股息不少于相关年度股东应占利润的40%[79] 公司运营相关 - 2018年至最新可行日期交付59艘工作船，21 - 25年平均年交付量在新加坡排第三，最新有5个在建项目，合同总值约460万新元[40] - 拥有约15.3万平方英尺滨水设施，2024年1月全面投入使用，船建造能力提升，2025年年产能约15艘[47] - 2024 - 2025年净流动资产增加[65][67] - 2023和2025年分别宣布支付约1090万和500万新元现金末期股息，2024年未宣布[82] 公司结构及成立信息 - 2026年1月2日在开曼群岛注册成立，名为Pinnacle Marine Holdings Ltd[106] - P Group、Pinnacle Marine、Prestige Ocean重组后是公司间接全资子公司[117][120] - 重组后林淑贞女士和蔡德坤先生分别持有Prompt Venture Limited 12.78%和87.22%股权[123] 财务费用及相关比例 - 股份名义价值为每股0.00001美元[7][126] - 股份经纪佣金为1%[7] - 证券及期货事务监察委员会交易征费为0.0027%[7] - 投资者赔偿征费为0.00015%[7] - 联交所交易费为0.00565%[7] - 与发行相关估计总费用约为[具体金额]新元，占发行总收益约[具体百分比][90] 采购与成本 - 2023 - 2025财年向五大供应商采购额分别约为940万、1120万和1070万新元，占销售成本比例分别约为38.4%、43.5%和39.2%[49] - 2023 - 2025财年最大供应商采购额分别约为240万、260万和260万新元，占比分别约为9.8%、10.2%和9.7%[49] - 2023 - 2025财年重叠交易对手采购额占总采购比例分别约为21.1%、22.0%和18.1%[50] - 船艇建造项目发动机等费用2023 - 2025财年分别约为330万、510万、760万新元，占销售总成本13.6%、19.7%、28.0%[154] - 2023 - 2025财年直接劳动力成本分别约为400万、400万、420万新元，占销售成本16.2%、15.5%、15.6%[165] - 2023 - 2025财年员工成本分别约为270万、420万、430万新元，占销售和管理费用43.1%、49.7%、50.7%[165] - 2023 - 2025财年燃料成本分别约为140万、200万、170万新元，占集团总收入成本5.6%、7.6%、6.3%[179] 风险提示 - 造船项目可能延迟、成本超支或取消销售合同[96][149] - 供应商供应问题、原材料成本增加、供应链中断[96] - 许可证问题影响业务和财务状况[96][160] - 员工成本增加、劳动力短缺[96][170] - 产品责任风险，保险可能无法完全覆盖损失[96][175] - 柴油和生物柴油价格波动或供应中断影响财务表现[179] - 船队老化和工作船重大停机增加运营成本并扰乱业务[184] - 依赖第三方服务提供商和海外代理，表现不佳影响业务和声誉[189] - 面临日益严格环境和排放控制要求，需额外投资和增加运营成本[198] - 数字通信和船舶跟踪系统故障扰乱业务[200]

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Radvance Cayman Limited (Incorporated in the Cayman Islands with limited liability) WARNING The publication of this announcement is required by Th ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Anhui Sinomags Technology Co., Ltd 安徽希磁科技股份有限公司 (the "Company") (A joint stock company incorporated in the People's ...